ALSTON & BIRD LLP

Lobbying for VERTEX PHARMACEUTICALS INCORPORATED · Pharmaceutical Manufacturer

Filing 2nd Quarter - Report

2nd Quarter (Apr 1 - June 30) 2026 · District of Columbia · House · Senate · $50,000.00 income · posted Jul 20, 2026

Lobbying activity 2

Budget/Appropriations

FY2027 Appropriations bills.

Health Issues

FY2027 Appropriations bills.

Source: federal Lobbying Disclosure Act filing. Bills are parsed from the activity descriptions.